Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries-Reference-Cited by-同舟云学术

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

Published:2020-05 Issue:5 Volume:2 Page:e250-e253
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Gianfrancesco Milena A,Hyrich Kimme L,Gossec Laure,Strangfeld Anja,Carmona Loreto,Mateus Elsa F,Sufka Paul,Grainger Rebecca,Wallace Zachary,Bhana Suleman,Sirotich Emily,Liew Jean,Hausmann Jonathan S,Costello Wendy,Robinson Philip,Machado Pedro M,Yazdany Jinoos

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference8 articles.

1. The risk of infections with biologic therapies for rheumatoid arthritis;Furst;Semin Arthritis Rheum,2010

2. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome;Kahl;J Rheumatol,1994

3. Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis;Kourbeti;Clin Infect Dis,2014

4. Infections and biologic therapy in rheumatoid arthritis: our changing understanding of risk and prevention;Winthrop;Rheum Dis Clin North Am,2012

5. A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19;Kim;Ann Intern Med,2020

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Effect in Pediatric Rheumatology Patients;Journal of Pediatric Infection;2024-06-25

2. Results of a 24-week open-label, non-interventional study on the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic;Modern Rheumatology Journal;2024-06-14

3. Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls;Clinical and Experimental Immunology;2024-05-20

4. Chinese expert consensus on diagnosis and treatment strategies for novel coronavirus infection in immunocompromised populations (2023 edition);International Journal of Rheumatic Diseases;2024-02

5. The effect of COVID-19 infection on patients with rheumatic diseases in China;Clinical Rheumatology;2024-01-29